Medication decisions are made by licensed clinicians after intake review, and the platform does not disclose available options in advance
By combining GLP-1, GIP and glucagon receptor activity into a single weekly injection, it has the potential to deliver greater weight loss than current therapies while also improving blood sugar control, metabolic health and markers of cardiovascular and liver disease
Fourthly, we used multiple imputation with chained equations to evaluate the influence of missing data on our findings for the following variables: smoking, body mass index, haemoglobin A 1c , and socioeconomic status (measured by the Index of Multiple Deprivation)
They may recommend temporarily adjusting your dose
This trial supported that at maximum tolerated dose, hydroxyurea is noninferior to blood transfusion
Clinical trials demonstrated 13.7 percent average body weight loss at 72 weeks, with many participants exceeding 15 percent